WhichRecall
Class IIReported 2024-12-18

Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817-77) and b) 1000-count bottles (NDC 0378-1817-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Recalled by Viatris Inc

Reason for Recall

Superpotent Drug and Subpotent Drug: potency failures obtained

Advertisement
Recall Number
D-0121-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2024-11-18
Reported
2024-12-18
Distribution
Nationwide within the United States and Puerto Rico
Code Info
Lot #: a) 3192915, 8172108, Exp. Date Mar 2025; b) 3208680, Exp. Date Sep 2025
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement